🚨 INJ IS BACK IN MOTION — BUT IS THE OPPORTUNITY STILL THERE?

Injective ($INJ ) is back on traders’ radar.

But a price rally alone isn’t a reason to buy.

Here’s what I’m watching 👇

1️⃣ INSTITUTIONAL INTEREST

Canary Capital has filed updated paperwork for a staked INJ ETF.

Important: a filing is not an approval. But progress here could become a meaningful catalyst.

2️⃣ A DIFFERENT TOKENOMICS STORY

Injective’s Community BuyBack burns INJ committed by participants while distributing a share of ecosystem revenue.

Less supply can help — but only if demand and network activity remain strong.

3️⃣ THE COMPETITION IS REAL

Hyperliquid and dYdX compete for on-chain trading activity.

INJ needs more than a strong chart. Its ecosystem must attract users, liquidity and sustainable revenue.

4️⃣ WHAT COULD COME NEXT?

🟢 Bullish scenario: institutional progress, growing on-chain activity and sustained buying volume.

🔴 Bearish scenario: the rally fades, adoption disappoints or broader altcoin momentum reverses.

My take: INJ is still worth watching. But I’d want confirmation from network activity and price structure before chasing a sharp move.

The real question isn’t how much INJ has already pumped.

It’s whether the fundamentals can support the next leg.

Not financial advice.

#INJ #CryptoAnalysis"